This observational study aims to develop a non-invasive (not requiring surgery or instruments to enter the body) diagnostic test for gynecological (female reproductive organ) cancers. This test would help rule out cancer in women aged 45 and older who experience abnormal uterine bleeding or bleeding after menopause. The study will look at how well this new test works, specifically its "sensitivity" (how well it correctly identifies those with the condition) over 12 months. Women between 45 and 100 years old can participate if they are willing to follow the study plan and can be contacted by phone. The current recruitment status is unclear, and the study plans to enroll about 4500 participants.

Study design

This is an observational study with a planned enrollment of 4500 women. The phase of the study is not specified.

What's involved

You would need to comply with scheduled visits, the study plan, and other procedures. You are expected to be available for the duration of the study and contactable by telephone.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, sensitivity, is measured at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.